Leading Clinical Research Expert MeDiNova Branches into East London
London-based clinical research
specialist MeDiNova has opened a third dedicated research centre in the capital
in order to meet increased demand for its services.
The agency – one of the top five in
the UK – has opened the East London Clinical Studies Centre, at Blackburn House
in Eastern Road, Romford.
The new centre will allow MeDiNova
to increase its intake of volunteers, particularly from across the East London
and Greater London areas. It will also allow MeDiNova to conduct health
screening for common conditions such as diabetes and respiratory problems and
to provide more regular monitoring for a range of other conditions.
Established in 1997 and at the very
forefront of pioneering developments within the clinical trials industry
MeDiNova also operates the North London Clinical Studies Centre at Mount Vernon
Hospital in Northwood and the South London Clinical Studies Centre at Queen
Mary’s Hospital in Sidcup. The group also operates the Madrid Clinical Studies
Centre in the Spanish capital.
Kumar Muthalagappan, Chief
Executive of MeDiNova, said the new centre will potentially allow MeDiNova to
extend its reach to thousands more people across East and Greater London.
He said: “Since it was founded in
1997 MeDiNova has continued to grow and is now widely recognised as one of the
top handful of clinical researchers in the UK.
“Our aim is to deliver quality
clinical trials data on time. In order to do so we work with many health
professionals and volunteers across our catchment area.
“As with our other two sites, the
East London Clinical Studies Centre is strategically located in an area of high
population density so we are able to deliver effective results on time and,
together with our volunteers, really help make a difference in shaping advances
in future treatments.”
Staffed by a 40-strong team of
professional research investigators, including fully qualified doctors and
nurses as well as admin staff, MeDiNova works closely with some of the world’s
leading pharmaceutical companies, CROs and biotech companies.
In the London area MeDiNova has
scanned more than 12,000 people for osteoporosis over the past two years, using
its DXA scanner, which measures bone mineral density.
Mr Muthalagappan added: “The
opening of our Romford clinic is part of our long-term plan to allow MeDiNova
to continue progressing by increasing our resources and building on our
achievements to date.
“Already we are able to conduct
trials in no less than 45 areas. Over time our three sites will allow us to
continue building on this offering and to reach out to potentially thousands
more residents across a far wider catchment area who will be able to benefit
from screening for a range of conditions including Osteoporosis, Diabetes and
For further information on the new centre, current studies or case studies please contact Celeste Clarke at Century PR on 024 76 228881 or email firstname.lastname@example.org.
- CLINICAL RESEARCH HAS CONTRIBUTED TO THE SUCCESS OF THE INFLUENZA VACCINE.
- MeDiNova helps to promote World Heart Day Saturday, 29 September 2018
- MeDiNova Research Supports World Pharmacists Day Tuesday, 25 September 2018
- MeDiNova promotes find the missing millions campaign
- MeDiNova helps promote Diabetes Week UK
- Clinical Trials
- Flu Vaccine Study
- Migraine sufferers urged to help in the fight against debilitating condition
- Leading Clinical Research Expert MeDiNova Branches into East London
- New COPD study to help reduce exacerbations and improve management for patients
- Do You Suffer From Eczema & Want To Try A New Novel Treatment?
- MeDiNova opens its new Dedicated Research Centre in Spain
- 2018 Oct
- 2018 Sep
- 2018 Jul
- 2018 Jun
- 2018 May
- 2018 Apr
- 2018 Mar
- 2017 Nov
- 2017 Sep
- 2017 Jun
- 2016 Jun
- 2016 Mar
- 2016 Jan
- 2015 Nov
- 2015 Oct